RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

ReShape Lifesciences Employees 2024

ReShape Lifesciences Employees

43

ReShape Lifesciences Dividend yield

Ticker

RSLS

ISIN

US7611236032

In 2024, ReShape Lifesciences employed 43 people, a 0% change from the 43 number of employees in the previous year.

ReShape Lifesciences Aktienanalyse

What does ReShape Lifesciences do?

ReShape Lifesciences Inc is a medical company that was founded in 2018 and is headquartered in San Clemente, California. The company is involved in the development and marketing of medical devices for the treatment of obesity and metabolic disorders. The company's business model focuses on innovative medical devices and services for the treatment of obesity and metabolic disorders. The company's main goal is to help patients improve their weight and health in a non-surgical way. The company offers not only medical devices but also services such as physician consulting, training for medical professionals, and patient support. The company's core products include the ReShape Vest, a non-invasive weight loss therapy approach, and the ReShape Duo System, a secondary gastric balloon system used in combination with a dietary program to support weight reduction. The company also offers the ReShape Care Plan, a comprehensive program for patients with obesity that is managed by a multidisciplinary team. The program includes individual sessions with a certified dietitian and a behavioral coach to motivate patients through concrete guidance for weight reduction. ReShape Lifesciences is dedicated to research and development of medical devices and services that help patients in weight reduction and improving their health. The company aims to create an affordable, safe, and effective treatment for obesity patients in an innovative manner that aligns with healthcare reform. ReShape Lifesciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining ReShape Lifesciences's Employee Base

ReShape Lifesciences's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding ReShape Lifesciences's operational capacity and future potential.

Year-to-Year Comparison

Assessing ReShape Lifesciences's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

ReShape Lifesciences's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in ReShape Lifesciences’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about ReShape Lifesciences Stock

How many employees does ReShape Lifesciences have this year?

ReShape Lifesciences has 43 undefined employees this year.

How many employees did ReShape Lifesciences have compared to the previous year?

Compared to the previous year, ReShape Lifesciences had 0% more employees.

What impact did the number of employees have on the company ReShape Lifesciences?

The number of employees has a direct impact on the efficiency and productivity of ReShape Lifesciences. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of ReShape Lifesciences?

The number of employees can also have an impact on investors of ReShape Lifesciences, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of ReShape Lifesciences affect the company?

An increase in equity of ReShape Lifesciences can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in ReShape Lifesciences's equity affect the company?

A reduction in equity of ReShape Lifesciences can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of ReShape Lifesciences?

Some factors that can influence the equity of ReShape Lifesciences include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of ReShape Lifesciences so important for investors?

The equity of ReShape Lifesciences is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at ReShape Lifesciences influence the company?

The number of employees at ReShape Lifesciences can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at ReShape Lifesciences evolved in recent years?

In recent years, the number of employees at ReShape Lifesciences has changed by 0.

How many employees does ReShape Lifesciences currently have?

ReShape Lifesciences currently has 43 undefined employees.

Why is the number of employees important for investors of ReShape Lifesciences?

The number of employees is important for investors of ReShape Lifesciences as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can ReShape Lifesciences take to change the number of employees?

To change the number of employees, ReShape Lifesciences can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does ReShape Lifesciences pay?

Over the past 12 months, ReShape Lifesciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ReShape Lifesciences is expected to pay a dividend of 0 USD.

What is the dividend yield of ReShape Lifesciences?

The current dividend yield of ReShape Lifesciences is .

When does ReShape Lifesciences pay dividends?

ReShape Lifesciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of ReShape Lifesciences?

ReShape Lifesciences paid dividends every year for the past 0 years.

What is the dividend of ReShape Lifesciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is ReShape Lifesciences located?

ReShape Lifesciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von ReShape Lifesciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ReShape Lifesciences from 5/23/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/23/2024.

When did ReShape Lifesciences pay the last dividend?

The last dividend was paid out on 5/23/2024.

What was the dividend of ReShape Lifesciences in the year 2023?

In the year 2023, ReShape Lifesciences distributed 0 USD as dividends.

In which currency does ReShape Lifesciences pay out the dividend?

The dividends of ReShape Lifesciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von ReShape Lifesciences

Our stock analysis for ReShape Lifesciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ReShape Lifesciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.